Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-016844
Filing Date
2017-03-27
Accepted
2017-03-27 17:01:51
Documents
1
Period of Report
2017-03-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v462723_4.html 4  
1 OWNERSHIP DOCUMENT v462723_4.xml 4 3997
  Complete submission text file 0001144204-17-016844.txt   5376
Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STELLAR BIOTECHNOLOGIES, INC. 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address
MORSE DANIEL E. (Reporting) CIK: 0001621331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 17715989